Annual Drug Patent Expirations for RECARBRIO
Recarbrio is a drug marketed by Msd Merck Co and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.
This drug has sixty-two patent family members in thirty-eight countries.
The generic ingredient in RECARBRIO is cilastatin sodium; imipenem; relebactam. One supplier is listed for this compound. Additional details are available on the cilastatin sodium; imipenem; relebactam profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
